Targeting the TGFβ signalling pathway in disease

Akhurst, Rosemary J., Hata, Akiko·2012·Nature Reviews Drug Discovery
DOI 10.1038/nrd3810

Cites (244)

Items 201–244 of 244

  1. Protein Tyrosine Phosphatases, New Targets for Cancer Therapy
    David J. Easty, William M. Gallagher, D. Bennett · 2006 · Current Cancer Drug Targets
  2. Gain or loss of TGF-β signaling in mammary carcinoma cells can promote metastasis
    Brian Bierie, Harold L. Moses · 2009 · Cell Cycle
  3. Peptide inhibitors of transforming growth factor‐β enhance the efficacy of antitumor immunotherapy
    Diana Llópiz, Javier Dotor, Noëlia Casares, Jaione Bezunartea, Nancy Díaz‐Valdés, Marta Ruiz, Fernando Aranda, Pedro Berraondo, Jesús Prìeto, Juan José Lasarte et al. · 2009 · International Journal of Cancer
  4. Inhibition of TGF-β modulates macrophages and vessel maturation in parallel to a lowering of interstitial fluid pressure in experimental carcinoma
    Alexei V. Salnikov, Pernilla Roswall, Christian Sundberg, Humphrey Gardner, Nils‐Erik Heldin, Kristofer Rubin · 2005 · Laboratory Investigation
  5. Pirfenidone treatment of idiopathic pulmonary fibrosis
    Arata Azuma · 2012 · Therapeutic Advances in Respiratory Disease
  6. Final results of a phase I/II study in patients with pancreatic cancer, malignant melanoma, and colorectal carcinoma with trabedersen.
    Helmut Oettle, Thomas Theodor Werner Seufferlein, Thomas Anton Luger et al. · 2012 · Journal of Clinical Oncology
  7. Strategies for TGF-β modulation: a review of recent patents
    D. Bonafoux, Wen‐Cherng Lee · 2009 · Expert Opinion on Therapeutic Patents
  8. Blockade of transforming growth factor-β signaling in tumor-reactive CD8+ T cells activates the antitumor immune response cycle
    Qiang Zhang, Ximing J. Yang, SHILAJIT D. KUNDU, Michael Pins, Borko Javonovic, Robert Meyer, Seong‐Jin Kim, Norman M. Greenberg, Timothy Michael Kuzel, Richard Meagher et al. · 2006 · Molecular Cancer Therapeutics
  9. Abstract 1: Mcl-1 downregulation plays a crucial role in the synergistic anticancer activities between PI-3 kinase inhibitors and histone deacetylase inhibitors in primary NSCLC tumors in vitro and in vivo
    Hao Zhang, Haikou Tang, Huanjie Shao, Chun Gao, Bonnie Lee Hylander, Elizabeth A. Repasky, Grace Kho Dy, Wen Wee Ma, Chunrong Yu, Alex A. Adjei · 2011 · Cancer Research
  10. A pyrrole–imidazole polyamide targeting transforming growth factor-β1 inhibits restenosis and preserves endothelialization in the injured artery
    En‐Hui Yao, Noboru Fukuda, Takahiro Ueno · 2008 · Cardiovascular Research
  11. Inhibition of ALK5 Signaling Induces Physeal Dysplasia in Rats
    Kendall S. Frazier, Roberta A. Thomas, Marshall S. Scicchitano, Rosanna C. Mirabile, Rogely Waite Boyce, Dawn M. Zimmerman, Eugene T. Grygielko, James B. Nold, Anne-Charlotte DeGouville, Stephane Huet et al. · 2007 · Toxicologic Pathology
  12. Pretranscriptional Regulation of Tgf-β1 by PI Polyamide Prevents Scarring and Accelerates Wound Healing of the Cornea After Exposure to Alkali
    Min Chen, Hiroyuki Matsuda, Linghua Wang et al. · 2009 · Molecular Therapy
  13. Immunotherapy for Human Renal Cell Carcinoma by Adoptive Transfer of Autologous Transforming Growth Factor β–Insensitive CD8+ T Cells
    Longxin Wang, Weihong Wen, Jianlin Yuan, Brian T. Helfand, Li Yu, Changhong Shi, Feng Tian, Jia Zheng, Fuli Wang, Lin Veronica Chen et al. · 2009 · Clinical Cancer Research
  14. Intimal Hyperplasia and Expression of Transforming Growth Factor-β1 in Saphenous Veins and Internal Mammary Arteries Before Coronary Artery Surgery
    Reinhard Friedl, Jun Li, Bernd A Schumacher · 2004 · The Annals of Thoracic Surgery
  15. Genetic variants of Tgfb1 act as context-dependent modifiers of mouse skin tumor susceptibility
    Jian‐Hua Mao, Elise F. Saunier, John P. de Koning, Margaret L. McKinnon, Mamie Nakayama Higgins, Kathy Nicklas, Haitao Yang, Allan Balmain, Rosemary J. Akhurst · 2006 · Proceedings of the National Academy of Sciences
  16. Protective effect of decorin on acute ischaemia-reperfusion injury in the rat kidney
    Cabir Alan, Hasan Koçoğlu, Ramazan Altıntaş · 2011 · Archives of Medical Science
  17. The TGF-beta1 antisense oligonucleotide AP 11014 for the treatment of non-small cell lung, colorectal and prostate cancer: Preclinical studies
    K.-H. Schlingensiepen, Astrid Bischof, Tamara Egger, Michael R. Hafner, Hedda Herrmuth, Piotr Jachimczak, M. Kielmanowicz, M. Niewel, Eva Závadová, Gerhard Stauder · 2004 · Journal of Clinical Oncology
  18. Pirfenidone Inhibits Obliterative Airway Disease in Mouse Tracheal Allografts
    Hailan Zhou, Christopher Latham, Dani S. Zander, Solomon B. Margolin, Gary A. Visner · 2005 · The Journal of Heart and Lung Transplantation
  19. TGF-beta signaling in atherosclerosis and restenosis
    Timothy A. McCaffrey · 2009 · Frontiers in Bioscience-Scholar
  20. Blocking TGFβvia Inhibition of theαvβ6 Integrin: A Possible Therapy for Systemic Sclerosis Interstitial Lung Disease
    Tamiko R. Katsumoto, Shelia M. Violette, Dean Sheppard · 2011 · International Journal of Rheumatology
  21. Smad-mediated miRNA processing
    Brandi N. Davis‐Dusenbery, Akiko Hata · 2011 · RNA Biology
  22. Adenovirus-mediated gene transfer of fibromodulin inhibits neointimal hyperplasia in an organ culture model of human saphenous vein graft disease
    Parisa Ranjzad, Husein K. Salem, Paul A. Kingston · 2009 · Gene Therapy
  23. Gene transfer of soluble transforming growth factor type II receptor by in vivo electroporation attenuates lung injury and fibrosis
    Mizuho Yamada, Kazuyoshi Kuwano, Takashige Maeyama · 2006 · Journal of Clinical Pathology
  24. Transcriptional Inhibition of Hypertrophic Scars by a Gene Silencer, Pyrrole–Imidazole Polyamide, Targeting the TGF-β1 Promoter
    Hisayo Washio, Noboru Fukuda, Hiroyuki Matsuda · 2011 · Journal of Investigative Dermatology
  25. First human dose (FHD) study of the oral transforming growth factor-beta receptor I kinase inhibitor LY2157299 in patients with treatment-refractory malignant glioma.
    J. Rodon Ahnert, José Baselga, Ezequiel Calvo et al. · 2011 · Journal of Clinical Oncology
  26. Inhibitory Effects of Tranilast on the Proliferation and Functions of Human Pterygium-derived Fibroblasts
    Masayuki Isaji, Shinji Kikuchi, Hiroshi Miyata · 2000 · Cornea
  27. Development and validation of a phosphorylated SMADex vivostimulation assay
    Daphne L. Farrington, Jonathan M. Yingling, Jeff A. Fill, Lei Yan, Y-W. Qian, Jianyong Shou, Xinkun Wang, M. E. Ehsani, Ann Cleverly, Thomas M. Daly et al. · 2007 · Biomarkers
  28. Trabedersen to target transforming growth factor- : when the journey is not the reward, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132-142)
    Wolfgang Wick, Michael Weller · 2011 · Neuro-Oncology
  29. Mouse T helper 17 phenotype: Not so different than in man after all
    Francesco Annunziato, Sergio Romagnani · 2011 · Cytokine
  30. Inhibition of transforming growth factor-β restores endothelial thromboresistance in vein grafts
    Navin Kumar Kapur, Ce Bian, Edward Lin · 2011 · Journal of Vascular Surgery
  31. Combination effect of a TGF‐β receptor kinase inhibitor with 5‐FU analog S1 on lymph node metastasis of scirrhous gastric cancer in mice
    Osamu Shinto, Masakazu Yashiro, Hidemi Kawajiri, Kiyoshí Shimizu, Toshiyuki Shimizu, Atsushi Miwa, Kosei Hirakawa · 2010 · Cancer Science
  32. Epistatic interactions between Tgfb1 and genetic loci, Tgfbm2 and Tgfbm3 , determine susceptibility to an asthmatic stimulus
    Julia Freimuth, Frederic F. Clermont, Xiaozhu Huang, Angela DeSapio, Taku A. Tokuyasu, Dean Sheppard, Rosemary J. Akhurst · 2012 · Proceedings of the National Academy of Sciences
  33. Long-term Follow-up After Lamellar Keratoplasty in a Patient With Bilateral Idiopathic Corneal Keloid
    Ken Fukuda, Tai-ichiro Chikama, Mutsuo Takahashi · 2011 · Cornea
  34. Management of Idiopathic Pulmonary Fibrosis
    Stefania Cerri, Paolo Spagnolo, Fabrizio Luppi, Luca Richeldi · 2011 · Clinics in Chest Medicine
  35. Convection-enhanced delivery of a transforming growth factor- 2 inhibitor trabedersen for recurrent high-grade gliomas: efficacy real or imagined?, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132-142)
    M. C. Chamberlain · 2011 · Neuro-Oncology
  36. The oral transforming growth factor-beta (TGF-ß) receptor I kinase inhibitor LY2157299 plus lomustine in patients with treatment-refractory malignant glioma: The first human dose study.
    Analía Azaro, José Baselga, Juan Manuel Sepúlveda-Sánchez et al. · 2012 · Journal of Clinical Oncology
  37. Stromedix acquisition signals growing interest in fibrosis
    Malorye Allison · 2012 · Nature Biotechnology
  38. CAT-152 Trabeculectomy Study
    2007 · Ophthalmology
  39. Effects of Avotermin (Transforming Growth Factor β 3 ) in a Clinically Relevant Pig Model of Long, Full-Thickness Incisional Wounds
    Hugh Laverty, Nick L. Occleston, Mark Johnson, John A. Little, Richard Jones, David M. Fairlamb, Mark W. J. Ferguson, Sharon O’Kane · 2010 · Journal of Cutaneous Medicine and Surgery
  40. Biogen acquires Stromedix to pursue novel fibrosis therapy
    Sarah Crunkhorn · 2012 · Nature Reviews Drug Discovery
  41. Abstract 5367: Long-term survival in a phase II atudy of belagenpumatucel-L (TGF-β antisense modified tumor cell vaccine) in non-small cell lung cancer (NSCLC).
    Lyudmila A. Bazhenova, Ewa Carrier, Daniel L. Shawler · 2012 · Cancer Research
  42. Smad7 gene transfer therapy: therapeutic applications beyond colonic fibrosis
    Shailendra N. Kapoor · 2008 · European Journal of Clinical Investigation
  43. Abstract 5234: Microenvironmental signals dictate disseminated tumor cells (DTCs) fate through regulation of TGFβII and p38α
    Paloma Bragado, Yeriel D. Estrada, María Soledad Sosa, Denis Martin Schewe, Carla S. Capobianco, Kateri Ann Moore, Hernán G. Fariña, Julio A. Aguirre‐Ghiso · 2012 · Cancer Research
  44. Abstract 1366: Development of murine models of breast cancer metastasis for the evaluation of the efficacy of TGF-β inhibitors as therapeutic agents
    Tanuka Biswas, Junhua Yang, Zhao Liu, Lu‐Zhe Sun · 2012 · Cancer Research